Abnormal Pap Test

References

Citations

1. Saslow D, et al. (2002). American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA: A Cancer Journal for Clinicians, 52(6): 342–362.

2. Hogewoning CJA, et al. (2003). Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial. International Journal of Cancer, 107(5): 811–816.

3. Plante M, et al. (1998). Management of the abnormal papanicolaou smear. Journal of the Society of Obstetricians and Gynaecologists of Canada, 20: 57–64.

4. Canadian Cancer Society (2006). Cervical cancer: Screening programs. Canadian Cancer Encyclopedia. Available online: http://info.cancer.ca/E/CCE/CCEDetails.asp?redirect=1&id=811&site=Cervical%20Cancer&lang=E&name=/CIS/E/CCE/HTML/12_811.html.

5. Sawaya GF, et al. (2003). Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine, 349(16): 1501–1509.

6. Sawaya GF, et al. (2000). The positive predictive value of cervical smears in previously screened postmenopausal women: The Heart and Estrogen/progestin Replacement Study (HERS). Annals of Internal Medicine, 133(12): 942–950.

7. Runowicz CD (2005). Approach to the patient with an abnormal Pap smear. In DC Dale, DD Federman, eds., ACP Medicine, section 16, chap. 16. New York: WebMD.

8. American College of Obstetricians and Gynecologists (2005). Management of abnormal cervical cytology and histology. ACOG Practice Bulletin No. 66. Obstetrics and Gynecology, 106(3): 645–664.

9. Melnikow J, et al. (1998). Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstetrics and Gynecology, 92(4): 727–735.

10. Sawaya GF, et al. (2001). Current approaches to cervical-cancer screening. New England Journal of Medicine, 344(21): 1603–1607.

11. Winer RL, et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine, 354(25): 2645–2654.

Other Works Consulted

• ASCUS–LSIL Triage Study (ALTS) Group (2003). A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology, 188(6): 1393–1400.

• Bosch FX, et al. (2001). Papillomavirus research update: Highlights of the Barcelona HPV 2000 International Papillomavirus Conference. Journal of Clinical Pathology, 54: 163–175.

• Bristow RE, Montz FJ (2001). Workup of the abnormal Pap test. Clinical Cornerstone, 3(1): 12–20.

• Cox JT, et al. (2003). Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. American Journal of Obstetrics and Gynecology, 188(6): 1406–1412.

• Cuzick J, et al. (2003). Management of women who test positive for high-risk types of human papillomavirus: The HART study. Lancet, 362 (9399): 1871–1876.

• Guido R, et al. (2003). Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA–positive atypical squamous cells of undetermined significance: A two-year prospective study. American Journal of Obstetrics and Gynecology, 188(6): 1401–1405.

• Kulasingam SL, Koutsky LA (2001). Will new human papillomavirus diagnostics improve cervical cancer control efforts? Current Infectious Disease Reports, 3: 169–180.

• Melnikow M, et al. (2002). Management of the low-grade abnormal Pap smear: What are women's preferences? Journal of Family Practice, 51(10): 849–855.

• Wong T, et al. (2006). Genital human papillomavirus (HPV) infections. Canadian Guidelines on Sexually Transmitted Infections, 2006 Edition. Ottawa: Public Health Agency of Canada. Available online: http://www.phac-aspc.gc.ca/std-mts/sti_2006/sti_intro2006_e.html.

• Wright TC, et al. (2003). 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. American Journal of Obstetrics and Gynecology, 189(1): 295–304.

Go to previous section	Go to top of page	Go to next section
Author:	Shannon Erstad, MBA/MPH Carrie Henley	Last Updated: April 10, 2007
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Anne C. Poinier, MD - Internal Medicine Barbara S. Apgar, MD, MS - Family Medicine, Women's Health Ross Berkowitz, MD - Obstetrics and Gynecology Deborah A. Penava, BA, MD, FRCSC, MPH - Obstetrics and Gynecology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.